Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Donna Skerrett Insider Profile
4 Followers
Donna Skerrett, Chief Medical Officer at Paradigm Biopharmaceuticals Ltd., holds 1.09M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF).
Donna Skerrett has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Donna Skerrett's holdings
Insider Roles
Chief Medical Officer
Roles that Donna Skerrett holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Donna Skerrett
Donna Skerrett's Trading History
List of latest transactions for each holding click on a transaction to see Donna Skerrett's performance on stock
You May Also Like
Donna Skerrett insider profile FAQ
What is the percentage of profitable transactions made by Donna Skerrett?
The percentage of profitable transactions made by Donna Skerrett is ―.
What is the average return per transaction made by Donna Skerrett?
The average return per transaction made by Donna Skerrett is ―.
What stocks does Donna Skerrett hold?
Donna Skerrett holds: PBIGF stocks.
What was Donna Skerrett’s latest transaction?
Donna Skerrett latest transaction was an Uninformative Buy of $708.75K.
What was Donna Skerrett's most profitable transaction?
Donna Skerrett’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Donna Skerrett's role in Paradigm Biopharmaceuticals Ltd.?
Donna Skerrett's role in Paradigm Biopharmaceuticals Ltd. is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.